Literature DB >> 6224759

The effects of dichloro-trans-dihydroxy-bis-isopropyl-amine-platinum IV on the primary cell-mediated cytotoxic response.

E Schlaefli, M J Ehrke, E Mihich.   

Abstract

The effects of diamino-dichloro-cis-platinum II (DDP) and dichloro-trans-bis-isopropyl-amine-platinum IV (DDIP or CHIP) on the primary cell-mediated cytotoxic (CMC) response developed in a mixed lymphocyte tumor cell culture (MLTC) were investigated. DDP as well as CHIP added on day 0 augmented the CMC response when spleen cells from C57Bl/6 mice were cultured for 4 days with supraoptimal numbers of irradiated (4000 rads) allogeneic P815 mastocytoma cells. A similar effect was observed when mice were treated with either of the two platinum compounds 1 or 5 days prior to spleen removal and sensitization of the spleen cells in a MLTC. Augmentation was not observed at optimal or suboptimal R:S. When spleen cells were preincubated with CHIP, only inhibitory effects on the CMC response could be demonstrated. Decreasing Cl- -ion concentrations in the preincubation medium increased the inhibitory effect of CHIP. After CHIP administration to spleen donor mice, the development of antigen specific suppressor cells was inhibited only at doses higher than those required to inhibit the development of nonspecific suppressor cells. Spleen responder cells from CHIP-treated donors exhibited a lower sensitivity to both antigen-specific and nonspecific suppressor cells than spleen responder cells from untreated control donors.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6224759     DOI: 10.1016/0162-3109(83)90004-8

Source DB:  PubMed          Journal:  Immunopharmacology        ISSN: 0162-3109


  3 in total

1.  The anticancer drug, cisplatin, increases the naturally occurring cell-mediated lysis of tumor cells.

Authors:  J L Collins; M S Kao
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  Immune response of mice exposed to cis-diamminedichloroplatinum.

Authors:  O Bagasra; L Currao; L R DeSouza; J W Oosterhuis; I Damjanov
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

3.  Effect of cisplatin upon expression of in vivo immune tumor resistance.

Authors:  E D Crum
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.